Biodesix, Inc. (BDSX)
26.02
+0.39
(+1.52%)
USD |
NASDAQ |
Oct 09, 16:00
26.02
0.00 (0.00%)
After-Hours: 20:00
Biodesix Enterprise Value : 316.21M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 316.21M |
| October 08, 2026 | 312.09M |
| October 07, 2026 | 320.43M |
| October 06, 2026 | 336.68M |
| October 05, 2026 | 348.28M |
| October 02, 2026 | 334.14M |
| October 01, 2026 | 330.03M |
| September 30, 2026 | 356.40M |
| September 29, 2026 | 349.12M |
| September 28, 2026 | 362.63M |
| September 25, 2026 | 348.70M |
| September 24, 2026 | 351.87M |
| September 23, 2026 | 350.71M |
| September 22, 2026 | 338.68M |
| September 21, 2026 | 341.63M |
| September 18, 2026 | 349.76M |
| September 17, 2026 | 345.64M |
| September 16, 2026 | 343.01M |
| September 15, 2026 | 333.93M |
| September 14, 2026 | 330.77M |
| September 11, 2026 | 326.18M |
| September 10, 2026 | 316.42M |
| September 09, 2026 | 327.39M |
| September 08, 2026 | 322.64M |
| September 04, 2026 | 317.90M |
| Date | Value |
|---|---|
| September 03, 2026 | 321.01M |
| September 02, 2026 | 328.24M |
| September 01, 2026 | 306.19M |
| August 31, 2026 | 319.64M |
| August 28, 2026 | 324.75M |
| August 27, 2026 | 342.16M |
| August 26, 2026 | 364.53M |
| August 25, 2026 | 337.89M |
| August 24, 2026 | 309.56M |
| August 21, 2026 | 322.64M |
| August 20, 2026 | 295.21M |
| August 19, 2026 | 311.14M |
| August 18, 2026 | 277.38M |
| August 17, 2026 | 286.99M |
| August 14, 2026 | 294.90M |
| August 13, 2026 | 292.68M |
| August 12, 2026 | 297.22M |
| August 11, 2026 | 298.17M |
| August 10, 2026 | 303.97M |
| August 07, 2026 | 289.62M |
| August 06, 2026 | 274.85M |
| August 05, 2026 | 282.03M |
| August 04, 2026 | 281.76M |
| August 03, 2026 | 274.11M |
| July 31, 2026 | 265.36M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Quest Diagnostics, Inc. | 31.55B |
| Labcorp Holdings, Inc. | 31.89B |
| OPKO Health, Inc. | 1.127B |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 2.394B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.273M |
| Revenue (Quarterly) | 26.86M |
| Total Expenses (Quarterly) | 34.13M |
| EPS Diluted (Quarterly) | -0.7064 |
| Gross Profit Margin (Quarterly) | 82.06% |
| Profit Margin (Quarterly) | -27.08% |
| Earnings Yield | -12.18% |
| Normalized Earnings Yield | -12.17 |